Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
22.7 HKD | -0.87% | -6.57% | +8.85% |
May. 14 | Calliditas Therapeutics Partner Offers Nefecon in China; Shares Rise | MT |
May. 14 | Everest Medicines Announces Commercial Launch and First Prescription for NEFECON in Mainland China | CI |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+8.85% | 965M | |
-3.15% | 89.69B | |
+2.50% | 41.34B | |
-12.01% | 33.72B | |
+62.74% | 26.11B | |
-19.79% | 14.63B | |
-8.58% | 12.84B | |
-12.34% | 11.66B | |
-43.92% | 11.52B | |
+4.27% | 8.92B |
- Stock Market
- Equities
- 1952 Stock
- News Everest Medicines Limited
- Transcript : Everest Medicines Limited, 2021 Earnings Call, Mar 29, 2022